Telix Pharmaceuticals TLX
NASDAQ TLX
$10.72 -0.25 (-2.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Liabilities and Shareholders Equity (2023 - 2026)

Updated

Telix Pharmaceuticals' Liabilities and Shareholders Equity came in at $1.36 billion for the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Telix Pharmaceuticals' Liabilities and Shareholders Equity was $1.16 billion, up 17.4% from the prior year.

  • Going back by year, Liabilities and Shareholders Equity was $991.68 million in the year ended Dec 31, 2024 (+275.2%) and $264.27 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Telix Pharmaceuticals 3.72 Bn 2.66 Bn - 1.36 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.36 Bn
Dec 31, 2025 1.16 Bn
Dec 31, 2024 991.68 Mn
Dec 31, 2023 264.27 Mn
API Access

Telix Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TLX&period=max&api_key=YOUR_API_KEY